NOTA:F Novartis AG

EUR 90.40 2.60 2.961276
Icon

Novartis AG (NOTA:F) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 90.40

+2.60 (+2.96)%

EUR 192.77B

55.00

N/A

N/A

Icon

NOTA:F

Novartis AG (EUR)
COMMON STOCK | F
EUR 90.40
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 192.77B

N/A

EUR 90.40

Novartis AG (NOTA:F) Stock Forecast

N/A

Based on the Novartis AG stock forecast from 0 analysts, the average analyst target price for Novartis AG is not available over the next 12 months. Novartis AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Novartis AG is Slightly Bullish , which is based on 5 positive signals and 4 negative signals. At the last closing, Novartis AG’s stock price was EUR 90.40. Novartis AG’s stock price has changed by +1.80% over the past week, -4.64% over the past month and +8.92% over the last year.

No recent analyst target price found for Novartis AG
No recent average analyst rating found for Novartis AG

Company Overview Novartis AG

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience...Read More

https://www.novartis.com

Lichtstrasse 35, Basel, Switzerland, 4056

76,057

December

EUR

Germany

Adjusted Closing Price for Novartis AG (NOTA:F)

Loading...

Unadjusted Closing Price for Novartis AG (NOTA:F)

Loading...

Share Trading Volume for Novartis AG Shares

Loading...

Compare Performance of Novartis AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for NOTA:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Novartis AG (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LLY:F
Eli Lilly and Company +7.00 (+0.98%) EUR710.53B 134.17 82.69

ETFs Containing NOTA

Symbol Name NOTA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Novartis AG (NOTA:F) Stock

Stock Target Advisor's fundamental analysis for Novartis AG's stock is Slightly Bullish .

NOTA:F stock's dividend yield is 3.77%. Our analysis grades NOTA:F stock's dividend yield at F. This means that NOTA:F stock's dividend yield is above 53% of the stocks in the Drug Manufacturers - General sector in the F exchange. Based on this NOTA:F may be a average dividend stock for its sector.

Unfortunately we do not have enough data on NOTA:F's stock to indicate what its average analyst target is.

NOTA:F stock's Price/Earning ratio is 24.59. Our analysis grades NOTA:F stock's Price / Earning ratio at F. This means that NOTA:F stock's Price/Earning ratio is above 42.00000000000001% of the stocks in the Drug Manufacturers - General sector in the F exchange. Based on this NOTA:F may be fairly valued for its sector

The last closing price of NOTA:F's stock was EUR 90.40.

The most recent market capitalization for NOTA:F is EUR 192.77B.

Unfortunately we do not have enough analyst data on NOTA:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Novartis AG's stock.

As per our most recent records Novartis AG has 76,057 Employees.

Novartis AG's registered address is Lichtstrasse 35, Basel, Switzerland, 4056. You can get more information about it from Novartis AG's website at https://www.novartis.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...